Dr. Thomas Hal Morley, M.D. Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 1980 Valley Brook Dr, Okemos, MI 48864 Phone: 517-347-8115 |
Lori Marie Burke, MD. Medicare: Accepting Medicare Assignments Practice Location: 4277 Okemos Rd Ste 100, Okemos, MI 48864 Phone: 517-816-8723 |
Jennifer Thome Hoffman, MD Medicare: Accepting Medicare Assignments Practice Location: 4277 Okemos Rd Ste 100, Okemos, MI 48864 Phone: 517-816-8723 Fax: 517-247-3558 |
News Archive
Researchers in the United States have conducted a study suggesting that the host response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within nasal mucosa is a key determinant of clinical trajectory in coronavirus disease 2019 (COVID-19).
RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutics, and EyeGate Pharma, the leader in non-invasive ocular drug delivery announced today that they will collaborate on the ocular delivery of RNAi therapeutics. Each party will contribute technology, expertise, and resources to the collaboration.
An increasing number of bacteria is evolving antibiotic resistance. Much-feared representatives of this steadily growing group include Staphylococci strains. At this point, multi-resistant forms of the bacterium Staphylococcus aureus - the "hospital germ" known commonly by its acronym, MRSA - can only be treated with a select subset of antibiotics as many drugs have simply stopped working. This is precisely why the field of medicine is in desperate need of new treatment options.
Elixir Medical Corporation, a developer of product platforms that combine innovative medical devices with potent pharmaceuticals for site-specific therapies, announced the initiation of patient enrollment in the EXCELLA BD Randomized Clinical Trial designed to evaluate Elixir's next generation Novolimus Eluting Coronary Stent System (CSS) with bioabsorbable coating, the Elixir DESyne BD Novolimus Eluting CSS.
The latest REACT-1 study findings from Imperial College London and Ipsos MORI show COVID-19 infection rates are three times lower for double vaccinated people.
› Verified 4 days ago